Kenvue

Despite its position in the personal care sector, an industry typically characterized by strong brand loyalty and high switching costs, Kenvue's moat score of 32/100 is surprisingly low.

This indicates that while the company possesses well-known brands, their competitive advantage is either eroding or proving insufficient to drive growth in the current market.

The most compelling evidence of this erosion is Kenvue's alarmingly low 3-year revenue CAGR of 0.1%, suggesting a significant struggle to expand market share or innovate effectively. While its TTM Gross Margin of 58.5% implies some premium pricing power for its existing product lines, this does not translate into sustainable top-line expansion.

The low moat score reflects a market where brand equity alone is not creating sufficient barriers to entry or allowing for sustained outperformance against competitors, possibly due to intense competition from private labels or faster-moving, innovative direct-to-consumer brands.

Kenvue's pricing power score of 39/100 suggests a challenging environment, despite its robust TTM Gross Margin of 58.5%. This high gross margin indicates that the company's established brands command a premium and consumers are willing to pay for perceived quality or trust.

However, the low pricing power score, in conjunction with a stagnant 3-year revenue CAGR of just 0.1%, implies that Kenvue struggles to consistently raise prices without negatively impacting sales volumes or market share.

The competitive landscape within personal care products, characterized by numerous alternatives and price-sensitive consumers, likely limits the company's ability to fully leverage its brand strength for significant price increases.

While the company can maintain attractive margins on current sales, it appears constrained in its ability to pass through cost inflation or drive organic growth through pricing adjustments, pointing to a delicate balance between price and volume in its core markets.

Kenvue's predictability score of 58/100 reflects a mixed outlook. As a consumer staples company in personal care, it benefits from relatively stable demand for its products, which generally contributes to consistent revenue and earnings streams compared to more cyclical industries. This inherent stability supports a baseline of predictability.

The company also demonstrates consistent profitability with a TTM Operating Margin of 14.6% and healthy TTM FCF of $2.68B, suggesting operational consistency. However, the extremely low 3-year revenue CAGR of 0.1% introduces a significant element of uncertainty regarding future growth prospects and market share stability.

While the core business is stable, the lack of top-line expansion means future performance heavily relies on cost management and market share defense rather than predictable organic growth, which can be less reliable.

Additionally, its recent spin-off status could introduce a period of adjustment as it fully establishes its independent operational and strategic direction.

Kenvue exhibits a notably conservative financial structure, reflected in a moderate financial strength score of 49/100 despite certain standout metrics.

Its Debt/Equity ratio of 0.18x is exceptionally low, indicating minimal reliance on external financing and providing substantial financial flexibility and resilience against economic downturns or rising interest rates. This is a significant positive for a company of its size.

The company also generates robust TTM FCF of $2.68B, translating to a healthy FCF margin of 7.8%, underscoring its operational efficiency in converting revenue to cash.

However, the TTM Current Ratio of 0.98x, while not a major concern for a consumer staples company with predictable cash flows, does suggest a relatively tight short-term liquidity position where current assets are just shy of covering current liabilities.

Overall, the strength from its low debt is somewhat tempered by the tight current ratio and the company's broader growth challenges.

The exceptionally low capital allocation score of 25/100 is a significant concern for Kenvue, indicating fundamental challenges in deploying capital effectively to drive shareholder value.

While the company generates substantial TTM Free Cash Flow of $2.68B and maintains an impressively low Debt/Equity ratio of 0.18x, these financial strengths do not appear to be translated into strategic growth. The most direct evidence of ineffective capital allocation is the anemic 3-year revenue CAGR of just 0.1%.

This suggests a failure to invest in areas that could stimulate top-line expansion, whether through innovative product development, strategic acquisitions, or market penetration initiatives.

Despite a high TTM ROE of 27.7%, this metric needs to be viewed cautiously, as it might reflect returns generated within a static or contracting revenue base rather than from effective investments in sustainable growth opportunities, raising questions about management's long-term strategic vision.

Kenvue's management score of 69/100 suggests competence in operational execution, yet it stands in interesting contrast with the very low capital allocation and stagnant revenue growth.

The management team appears effective in maintaining robust profitability, as evidenced by a TTM Gross Margin of 58.5% and a TTM Operating Margin of 14.6%, demonstrating strong control over costs and supply chains within the existing business.

Furthermore, the generation of TTM FCF of $2.68B and an impressive TTM ROE of 27.7% highlight their ability to extract value from current assets. However, the low capital allocation score of 25/100 and the dismal 3-year revenue CAGR of 0.1% strongly suggest a significant weakness in strategic planning and deployment of capital for long-term growth.

While capable of managing the day-to-day operations and current profitability, the scores imply a challenge in adapting to market changes, fostering innovation, and identifying compelling investment opportunities to expand Kenvue's competitive footprint and revenue base.